Company intelligence / Profile preview

Lasilactone

Paris, France

Ownership: Private
Employees: ~91000
Development stage: Other

Overview

Sanofi is a global pharmaceutical leader focused on developing innovative therapeutic solutions across a wide range of medical fields. The company is the manufacturer of Lasilactone, a fixed-dose combination of the diuretics furosemide and spironolactone, which is used to treat resistant edema and hypertension. Sanofi's operations are divided into several key business units, including Specialty Care (Sanofi Genzyme), Vaccines (Sanofi Pasteur), and General Medicines. With a strong emphasis on research and development, the company maintains a diverse pipeline targeting immunology, oncology, and rare diseases.

Therapeutic areas: CardiovascularEndocrinologyDermatologyPulmonology
Modalities: Small moleculeMonoclonal antibodyVaccinePeptidesRNA therapy
Industry: Pharma

Partnerships

RegeneronAstraZenecaBioNTech

Beyond the preview

Go deeper on Lasilactone.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lasilactone.

Explore the full profile